Characteristics of the LncRNA datasets in DoSurvive.
Number of Patients tested with LncRNA.
| Cancer Types | Patients (OS) | Patients (DSS) | Patients (DFI) | Patients (PFI) | Gene (OS) |
| Bladder Urothelial Carcinoma (BLCA) | 251 | 245 | 115 | 252 | 4572 |
| Breast invasive carcinoma (BRCA) | 837 | 819 | 729 | 837 | 4973 |
| Cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) | 196 | 194 | 127 | 196 | 4475 |
| Colon adenocarcinoma (COAD) | 157 | 157 | 76 | 157 | 1388 |
| Glioblastoma multiforme (GBM) | 153 | 140 | 1 | 153 | 5555 |
| Head and Neck squamous cell carcinoma (HNSC) | 427 | 404 | 117 | 427 | 4179 |
| Kidney Chromophobe (KICH) | 65 | 65 | 29 | 65 | 4605 |
| Kidney renal clear cell carcinoma (KIRC) | 461 | 450 | 79 | 460 | 5317 |
| Kidney renal papillary cell carcinoma (KIRP) | 197 | 194 | 106 | 196 | 4822 |
| Brain Lower Grade Glioma (LGG) | 484 | 476 | 123 | 484 | 5629 |
| Liver hepatocellular carcinoma (LIHC) | 200 | 195 | 157 | 200 | 3711 |
| Lung adenocarcinoma (LUAD) | 480 | 446 | 285 | 480 | 5093 |
| Lung squamous cell carcinoma (LUSC) | 217 | 189 | 108 | 217 | 4993 |
| Ovarian serous cystadenocarcinoma (OV) | 410 | 380 | 198 | 410 | 5278 |
| Prostate adenocarcinoma (PRAD) | 374 | 373 | 279 | 374 | 4928 |
| Rectum adenocarcinoma (READ) | 71 | 71 | 18 | 71 | 1391 |
| Skin Cutaneous Melanoma (SKCM) | 216 | 212 | 0 | 217 | 4336 |
| Stomach adenocarcinoma (STAD) | 284 | 265 | 172 | 284 | 5052 |
| Uterine Corpus Endometrial Carcinoma (UCEC) | 316 | 316 | 264 | 316 | 1497 |
*OS: Overall survival, DSS: Disease-specific survival, DFI: Disease-free survival, PFI: Progression-free survival